Cargando…
Base and Prime Editing Technologies for Blood Disorders
Nuclease-based genome editing strategies hold great promise for the treatment of blood disorders. However, a major drawback of these approaches is the generation of potentially harmful double strand breaks (DSBs). Base editing is a CRISPR-Cas9-based genome editing technology that allows the introduc...
Autores principales: | Antoniou, Panagiotis, Miccio, Annarita, Brusson, Mégane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525391/ https://www.ncbi.nlm.nih.gov/pubmed/34713251 http://dx.doi.org/10.3389/fgeed.2021.618406 |
Ejemplares similares
-
Editorial: Mutation-Specific Gene Editing for Blood Disorders
por: Lederer, Carsten Werner, et al.
Publicado: (2021) -
Prime editing in hematopoietic stem cells—From ex vivo to in vivo CRISPR-based treatment of blood disorders
por: Wolff, Jonas Holst, et al.
Publicado: (2023) -
Prime Editing for Inherited Retinal Diseases
por: da Costa, Bruna Lopes, et al.
Publicado: (2021) -
piggyPrime: High-Efficacy Prime Editing in Human Cells Using piggyBac-Based DNA Transposition
por: Wolff, Jonas Holst, et al.
Publicado: (2021) -
Spelling Changes and Fluorescent Tagging With Prime Editing Vectors for Plants
por: Wang, Li, et al.
Publicado: (2021)